지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2003.6
- 수록면
- 112 - 117 (6page)
이용수
초록· 키워드
오류제보하기
Depression in older patients contributes to personal suffering and family disruption and increases disability, medical morbidity, mortality, suicide risk, and healthcare utilization. Older patients often have serious coexisting medical conditions that may contribute to the depression and complicate the choice of treatment. Older adults metabolize medication slowly and more sensitive to side effects than younger patients. Because of these complexities, we should be careful in prescribing antidepressants at depressive disorders in older patients.
For unipolar non psychotic major depression, the preferred strategy is an antidepressants(SSPI or venlafaxine XR preferred) plus psychotherapy. For unipolar psychotic depression, the treatment of choice is an antidepressant (SSRI or venlafaxine XR) plus one of the newer atypical antipsychotics. Electroconvulsive therapy is also first line. For dysthymic disorder or persistent milder depression. combination of antidepressant(SSRI preferred) and psychotherapy is recommend.
If the patient has a comorbid medical condition(e.g., hypothyroidism) that is contributing to the depression, treating both the depression and the medical condition from the outset is recommended.
The SSRIs were the top-rated antidepressants for all type of depression. The preferred psychotherapy techniques for treating depression in older patients are cognitive-behavioral therapy, supportive psychotherapy, problem-solving psychotherapy, and interpersonal psychotherapy. Also, appropriate psychosocial interventions(e.g., psychoeducation, family counseling, visiting nurse services) are needed in treatment program.
Continuing treatment with antidepressants for at least 1 year is recommended if a patient has had a single episode of severe unipolar major depression, for 1-3 year for a patient who has 2 such episodes, and for longer than 3 years if there is a history of 3 or more episodes.
For unipolar non psychotic major depression, the preferred strategy is an antidepressants(SSPI or venlafaxine XR preferred) plus psychotherapy. For unipolar psychotic depression, the treatment of choice is an antidepressant (SSRI or venlafaxine XR) plus one of the newer atypical antipsychotics. Electroconvulsive therapy is also first line. For dysthymic disorder or persistent milder depression. combination of antidepressant(SSRI preferred) and psychotherapy is recommend.
If the patient has a comorbid medical condition(e.g., hypothyroidism) that is contributing to the depression, treating both the depression and the medical condition from the outset is recommended.
The SSRIs were the top-rated antidepressants for all type of depression. The preferred psychotherapy techniques for treating depression in older patients are cognitive-behavioral therapy, supportive psychotherapy, problem-solving psychotherapy, and interpersonal psychotherapy. Also, appropriate psychosocial interventions(e.g., psychoeducation, family counseling, visiting nurse services) are needed in treatment program.
Continuing treatment with antidepressants for at least 1 year is recommended if a patient has had a single episode of severe unipolar major depression, for 1-3 year for a patient who has 2 such episodes, and for longer than 3 years if there is a history of 3 or more episodes.
목차
영어 초록
서론
본론
결론
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
근거중심 한국형 우울증 약물학적 치료지침, 개정판 (I) : 항우울제 치료의 초기선택
신경정신의학
2013 .01
-
SSRIs 이후의 항우울제
생물정신의학
1999 .01
-
우울증과 항우울작용에 관한 p11(S100A10)의 역할
생물정신의학
2016 .01
-
Antidepressant Prescribing Patterns in Korea: Results from the Clinical Research Center for Depression Study
PSYCHIATRY INVESTIGATION
2011 .01
-
항우울제와 자살
생물정신의학
2006 .01
-
새로운 우울증 치료 약물
생물정신의학
2016 .01
-
암환자 우울증의 약물중재
신경정신의학
2010 .01
-
미래의 항우울제
생물치료정신의학
2011 .12
-
근거중심 한국형 우울증 약물학적 치료지침, 개정판(III) : 항우울제의 증량, 교체, 병합 및 강화요법
신경정신의학
2013 .01
-
기분부전장애와 비전형우울증의 약물치료
생물정신의학
2007 .01
-
한국에서 우울증의 특징과 비약물학적 치료
생물정신의학
2006 .01
-
만성통증 환자에서 항우울제의 사용
The Korean Journal of Pain
2004 .01
-
비정형 우울증의 역동정신치료
생물치료정신의학
1997 .06
-
암 환자의 우울증
생물정신의학
2006 .01
-
근거중심 한국형 우울증 약물학적 치료지침, 개정판(II) : 항우울제의 위약대비 효과, 항우울제간 효과차이 및 효과판정의 적정시점
신경정신의학
2013 .01
-
Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting
PSYCHIATRY INVESTIGATION
2010 .01
-
The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) Study: Design and Methodology
PSYCHIATRY INVESTIGATION
2018 .01
-
신체질환 환자들에서 우울증의 평가 및 치료
정신신체의학
2001 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-017221904